Login to Your Account

Ampio seeks $59.5M to move pain candidate Ampion to goal line

Friday, February 28, 2014
Ampio Pharmaceuticals Inc. priced an underwritten public offering of 8.5 million shares of common stock at $7 apiece, seeking to raise $59.5 million. The offering price represented a discount of 11.8 percent to Ampio’s (NYSE MKT:AMPE) closing price of $7.94 on Thursday, but the offering was upsized from the 8 million shares cited in the company’s preliminary prospectus supplement, dated Feb. 24.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription